Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Lithium-induced decrease in spontaneous Ca2+ oscillations in single GH3 rat pituitary cells

M A Varney1, A Galione, S P Watson

  • 1University Department of Pharmacology, Oxford.

British Journal of Pharmacology
|June 1, 1994
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

N-acetyl-L-leucine for Niemann-Pick type C: a multinational double-blind randomized placebo-controlled crossover study.

Trials·2023
Same author

Acute and Repeated Administration of NLX-101, a Selective Serotonin-1A Receptor Biased Agonist, Reduces Audiogenic Seizures in Developing Fmr1 Knockout Mice.

Neuroscience·2022
Same author

NLX-112, a highly selective 5-HT<sub>1A</sub> receptor biased agonist, does not exhibit misuse potential in male rats or macaques.

Neuropharmacology·2022
Same author

A master protocol to investigate a novel therapy acetyl-L-leucine for three ultra-rare neurodegenerative diseases: Niemann-Pick type C, the GM2 gangliosidoses, and ataxia telangiectasia.

Trials·2021
Same author

Bell-shaped agonist activation of 5-HT<sub>1A</sub> receptor-coupled Gαi<sub>3</sub> G-proteins: Receptor density-dependent switch in receptor signaling.

Cellular signalling·2019
Same author

NLX-112, a highly selective 5-HT<sub>1A</sub> receptor agonist, mediates analgesia and antidepressant-like activity in rats via spinal cord and prefrontal cortex 5-HT<sub>1A</sub> receptors, respectively.

Brain research·2018
Same journal

Glucagon-like peptide-1 improves vascular endothelial dysfunction in hypertensive mice via CREB-driven transcriptional regulation of long non-coding RNA 155383.

British journal of pharmacology·2026
Same journal

The chemokine receptor-like fourth extracellular loop of the apelin receptor differentially regulates apelin and elabela binding and signalling.

British journal of pharmacology·2026
Same journal

Peripheral targets for neuropathic pain.

British journal of pharmacology·2026
Same journal

Therapeutic potential of liver X receptor agonist GW3965 in preserving myelin integrity following traumatic brain injury.

British journal of pharmacology·2026
Same journal

The role of protein arginine methyltransferases in sickle cell-mediated neurovascular impairments in mice.

British journal of pharmacology·2026
Same journal

β-Cyclodextrin inclusion enhances the pro-resolving effects of the annexin A1 mimetic Ac2-26 in a mouse model of antigen-induced arthritis.

British journal of pharmacology·2026
See all related articles

Lithium treatment alters calcium signaling in rat pituitary cells, reducing basal oscillations. This finding may explain lithium

Area of Science:

  • Cellular signaling
  • Neuroendocrinology
  • Pharmacology

Background:

  • Rat pituitary GH3 cells exhibit variable intracellular calcium ([Ca2+]i) signaling patterns.
  • Previous studies showed lithium (Li+) reduces inositol 1,4,5-trisphosphate levels in GH3 cells.

Purpose of the Study:

  • To investigate the effect of chronic lithium treatment on intracellular calcium signaling in GH3 cells.
  • To understand the impact of lithium on basal and TRH-stimulated calcium responses.

Main Methods:

  • Dynamic single-cell imaging of [Ca2+]i in GH3 cells.
  • Treatment of GH3 cells with 1 mM Li+ for 7 days.
  • Measurement of inositol 1,4,5-trisphosphate levels.
  • Agonist stimulation with thyrotrophin-releasing hormone (TRH).

Related Experiment Videos

Main Results:

  • Lithium treatment reduced the number of cells showing basal Ca2+ oscillations.
  • Peak intracellular calcium increases induced by TRH were diminished in lithium-treated cells.
  • Lithium did not affect the amplitude of Ca2+ oscillations or phosphoinositide pathway sensitivity.

Conclusions:

  • Chronic lithium treatment alters Ca2+ signaling by reducing basal oscillations in GH3 cells.
  • These changes in calcium signaling may contribute to the therapeutic efficacy of lithium in treating manic depression.